BYRN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BYRN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has improved short-term momentum, but the broader trend is still bearish, recent earnings showed margin and profit deterioration, and analyst revisions have turned sharply more cautious. With no strong proprietary buy signal and ongoing negative news flow, I would not buy here and would wait for clearer fundamental and technical improvement.
Current price is 5.535, essentially flat on the day, but the longer trend remains weak. The MACD histogram is positive and expanding, which suggests near-term momentum has improved. However, RSI_6 at 34.74 is only neutral to slightly weak, and the moving average structure is bearish with SMA_200 > SMA_20 > SMA_5. Key levels show pivot at 5.71, resistance at 6.062 and 6.279, with support at 5.359 and 5.142. Overall, the chart is still in a fragile downtrend despite a modest bounce attempt.
Revenue in Q1 2026 increased 10.92% year over year to 29.05M, showing the business is still growing top-line. Gross margin remains relatively healthy at 59.9%. The company also has a debt-free balance sheet and strong free cash flow according to analyst commentary. Option positioning is bullish, and the short-term technical momentum has turned mildly positive.
Net income fell 51.81% year over year and EPS dropped 57.14%, showing profitability pressure despite revenue growth. Gross margin also declined 1.48% year over year. News flow is unfavorable due to Pomerantz LLP investigating potential securities fraud claims and the reported decline in online sales performance. The stock already suffered a sharp post-earnings drop, and the company is facing a leadership transition and marketing pivot that analysts expect will take time. The broader price trend remains bearish.
Latest quarter: Q1 2026. Revenue rose to 29,049,000, up 10.92% YoY, which is positive. But profitability weakened materially, with net income down 51.81% YoY to 801,000 and EPS down 57.14% YoY to 0.03. Gross margin slipped to 59.9%, down 1.48% YoY. In short, the company is still growing sales, but earnings quality and margins are deteriorating.
Recent analyst action has turned mixed to bearish. Roth Capital kept a Buy but cut its target sharply from 26 to 12.50, B. Riley reduced its target from 31 to 21 while maintaining Buy, and Craig-Hallum downgraded the stock to Hold with a 7.50 target. Texas Capital initiated coverage with a Buy and 20 target, citing retailer partnerships and a strong balance sheet. Wall Street's bullish case is long-term growth from channel expansion and margin recovery; the bearish case is that estimates are too high, the CEO transition and marketing reset will take time, and profitability could stay under pressure.
